NCT02447666 2019-07-11Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)CelgenePhase 2 Completed28 enrolled 1 FDA
NCT00171912 2017-02-23Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesNovartisPhase 2 Completed38 enrolled